[Sublobar resection for non-small cell lung cancer in Iceland]. 2011

Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson

A sublobar resection is performed on patients with non-small cell lung cancer (NSCLC) who are not candidates for a lobectomy due to reduced pulmonary function or comorbid disease. The aim of this study was to investigate the outcomes of these operations in Iceland. A retrospective study of all patients with NSCLC who underwent wedge resection or segmentectomy with curative intent during 1994-2008. Data on indication, pathological TNM-stage, complications and overall survival was analyzed. All histological samples were re-evaluated. Forty four patients underwent 42 wedge and 5 segmental resections (age 69.1 yrs, 55.3% female), with 38.3% of cases detected incidentally. The majority of patients (55.3%) had a history of coronary artery disease and 40.4% had chronic obstructive pulmonary disease. Mean operative time was 83 minutes (range 30-131), mean intraoperative bleeding was 260 ml (range 100-650) and median hospital stay was 9 days (range 4-24). Pneumonia (14.9%) and prolonged air leakage (12.8%) were the most common complications. Two patients had major complications and 36.2% stayed in the intensive care unit overnight. No deaths occurred within 30 days of surgery. Adenocarcinoma was the most common histological type (66.7%). Most cases were stage IA/IB (78.7%), 17.0% were stage IIA/IIB and 4.3% were stage IIIA. One and 5 year survival was 85.1% and 40.9% respectively. In Iceland, both survival and complication rate after sublobar resection for NSCLC are comparable to results published for lobectomies, even though a higher percentage of patients have underlying cardiopulmonary disease.

UI MeSH Term Description Entries
D007055 Iceland A country in northern Europe, an island between the Greenland Sea and the North Atlantic Ocean, northwest of the United Kingdom. The capital is Reykjavik.
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
November 2012, Bulletin du cancer,
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
January 2013, Seminars in thoracic and cardiovascular surgery,
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
April 2017, Journal of thoracic disease,
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
April 2023, Chirurgie (Heidelberg, Germany),
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
November 2014, Lung cancer (Amsterdam, Netherlands),
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
April 2024, Current oncology (Toronto, Ont.),
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
August 2023, World journal of surgery,
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
December 2017, The Korean journal of thoracic and cardiovascular surgery,
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
June 2023, The Annals of thoracic surgery,
Asgeir Alexandersson, and Steinn Jonsson, and Helgi J Isaksson, and Tomas Gudbjartsson
October 2006, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!